Anti-Human CD19 Magnetic Particles - DM
CD19：a validated therapeutic target for B-cell malignancies - ACROBiosystems
CD19 CAR antigen engagement mechanisms and affinity tuning | Science Immunology
Anti-CD28 stimulation of CD19-chimeric antigen receptors (CAR) T... | Download Scientific Diagram
The QCM frequency shifts of the main steps for the CD19 immobilization... | Download Scientific Diagram
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial | Nature Medicine
The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies:a meta-analysis | BMC Cancer | Full Text
CD19 Positive Cell Isolation Kit
Phospho-CD19 (Tyr531) Antibody | Cell Signaling Technology
Cancers | Free Full-Text | CD19 Chimeric Antigen Receptor-Exosome Targets CD19 Positive B-lineage Acute Lymphocytic Leukemia and Induces Cytotoxicity
Dynabeads™ CD19 Pan B
Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies | Hematology, Transfusion and Cell Therapy
Evaluation of piggyBac‐mediated anti‐CD19 CAR‐T cells after ex vivo expansion with aAPCs or magnetic beads - Yang - 2021 - Journal of Cellular and Molecular Medicine - Wiley Online Library
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models | Science Translational Medicine
Cancers | Free Full-Text | CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1− Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B Cells
Multiplexing single cell measurement of CAR-T cells in microchambers. a... | Download Scientific Diagram
Frontiers | Cytokines induced memory-like NK cells engineered to express CD19 CAR exhibit enhanced responses against B cell malignancies
Part:BBa K4040015 - parts.igem.org
Human CD19 Magnetic Beads MS005 | Proteintech
Cryopreserved anti-CD22 and bispecific anti-CD19/22 CAR T cells are as effective as freshly infused cells: Molecular Therapy Methods & Clinical Development
Anti-rabbit CD19 Recombinant Antibody – Cobalt Biologics
Anti-Human CD19 Magnetic Particles - DM
Establishing CD19 B-cell reference control materials for comparable and quantitative cytometric expression analysis | PLOS ONE
